Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Early onset (childhood) monogenic neuropathies.
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Neuroimmunological diseases and pregnancy.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Impact of high intensity exercise on muscle morphology in EAE rats.
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
[Diagnosis of multiple sclerosis].
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Myelination: Do Astrocytes Play a Role?
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
[Pathogenesis of neuromyelitis optica].
Surgical Outcomes of Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Living with multiple sclerosis.
The prevalence of incidental findings in multiple sclerosis patients.
Pages
« first
‹ previous
…
300
301
302
303
304
305
306
307
308
…
next ›
last »